po semaglutide Sem-P™ - Getz Pharma grepmed - Semaglutide (Rybelsus) -

**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program

DNA was extracted by adding 25 Mm NaOH, containing 0.2 mM EDTA N2 and 40 mM TrisHCl, to the sample tissue

A new study finds that semaglutide (sold under the brand names Ozempic and Wegovy) influences taste sensitivity and how the brain responds to sweet tastes

Based on the STEP-1 clinical trial, the average weight loss with semaglutide 2.4 mg weekly is 14.9% of body weight over 68 weeks (about 16 months)

Two-thirds of 122 medications tested stayed effective for at least four additional years